Clinical Research Directory
Browse clinical research sites, groups, and studies.
Efficacy of Hi-tACS for Schizophrenia Negative Symptoms
Sponsor: Shanghai Mental Health Center
Summary
The goal of this clinical trial is to investigate whether Hi-tACS is effective and safe in treating negative symptoms of schizophrenia. Schizophrenic patients will receive treatment (Hi-tACS or shame stimulation) for 2 weeks. Negative symptoms, cognitive functioning, social functioning, and quality of life of intervention group and control group were assessed and compared between the two groups at baseline, 2 weeks, and 3 months post-intervention.
Official title: Efficacy of High-Intensity Transcranial Alternating Current Stimulation (Hi-tACS) in Treating Negative Symptoms of Schizophrenia
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2024-06-27
Completion Date
2026-11-30
Last Updated
2025-06-04
Healthy Volunteers
No
Interventions
High-intensity transcranial alternating current stimulation (Hi-tACS)
The equipment used is the transcranial microcurrent stimulator (Nexalin ADI), operated by trained therapists following standardized instructions. Three Nexalin conductive electrodes are placed on the patient's head. A 4.45×9.53 cm electrode is placed on the forehead, corresponding to the Fpz region of the 10/20 international standard electrode placement system. Two 3.18×3.81 cm electrodes are placed on the bilateral dorsolateral prefrontal cortex, corresponding to the F3 and F4 regions of the international standard electrode placement system. The stimulation frequency is 77.5 Hz, and the current intensity is 15 mA.
Sham High-intensity transcranial alternating current stimulation (Sham-Hi-tACS)
A sham device looks exactly the same as Nexalin ADI is used.
Locations (1)
Shanghai Mental Health Center
Shanghai, Shanghai Municipality, China